Abstract
During the past two years, porcine-derived, xenogeneic extracellular matrix (ECM) has been used as a scaffold for several tissue engineering applications in more than 100,000 human patients. ECM contain numerous growth factors that are arranged in a unique ultrastructure that supports constructive tissue remodeling. A review is given of the clinical experience, including the immunologic response of the patients to this xenogenetic scaffold.
| Original language | English |
|---|---|
| Pages (from-to) | 752 |
| Number of pages | 1 |
| Journal | Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings |
| Volume | 1 |
| State | Published - 2002 |
| Externally published | Yes |
| Event | Proceedings of the 2002 IEEE Engineering in Medicine and Biology 24th Annual Conference and the 2002 Fall Meeting of the Biomedical Engineering Society (BMES / EMBS) - Houston, TX, United States Duration: 23 Oct 2002 → 26 Oct 2002 |
Fingerprint
Dive into the research topics of 'Clinical experience with an ECM scaffold for tissue engineering. The 2nd joint conference of the IEEE engineering in medicine and biology society and the biomedical engineering society'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver